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Background: The PROtocolized Care to Reduce HYpotension after Spinal Anaesthesia (ProCRHYSA trial) is
an unblinded, randomized, monocentric, prospective, three-arm, parallel-group trial aimed at assessing
the role of a controlled volemic repletion in reducing both clinically signiﬁcant hypotension rate and total
amount of ﬂuid administered in patients undergoing spinal anaesthesia.
Methods/Design: Aim of the study is assessing the effectiveness of a non-invasive tests to guide a titrated
volemic repletion before spinal anesthesia in order to reduce post-spinal hypotension rate. After local
ethical committee approval of the study (Comitato Etico Cantonale Ref. N. CE2796), we will randomize
patients undergoing elective surgery under spinal anesthesia into two parallel groups: in the ﬁrst vena
cava ultrasound will be used in order to assess adequacy of patients’ volemic status and consequently
guide the administration of crystalloids boluses; in the second passive legs raising test will be used
instead of ultrasound for the same purpose.
Discussion: The hypothesis we want to test is that the using of these two experimental methods before
spinal anaesthesia, compared to the standard method (empirical ﬂuid administration) can reduce the
impact of systemic hypotension through an adequate titrated volemic repletion, avoiding both hypo-
tension and ﬂuid overload. The ﬁnal purpose is to ensure that spinal anaesthesia is performed in the
safest way possible.
Conclusions: The study will offer a new insight on the possible role of vena cava ultrasound and passive
legs raising test as screening tools to prevent hypotension after spinal anesthesia. These tests were
already validated in a critical environment, but to the best of our knowledge this is the ﬁrst time they are
applied to an elective surgical population.
Trial registration: The trial was registered on May 2014 on www.clinicalstrial.gov with the number
NCT02070276.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Spinal anaesthesia is an ubiquitous clinical practice, its most
feared and common side effect consisting of an abrupt reduction of
systemic vascular resistances and a consequent risk of systemic
hypotension [1e3]. To prevent this complication, an adequate
correction of patients’ volume status is often obtained through aeruti), bruno.minotti@eoc.ch
la.decristophoris@gmail.com
selmi), andrea.saporito@eoc.
Inc. This is an open access article upreventive ﬂuids administration [4e7].
Volume repletion is usually accomplished empirically, without
having a real evaluation of patient’s hemodynamic status; this
practice carries the risk of possible volume overload. The using of
non-invasivemethods has been proved to be accurate in identifying
patients’ ﬂuid-responsiveness [8,9]; however it has not been
investigated yet in this speciﬁc setting [10].
Ultrasound of inferior vena cava (IVC) studied by Trans-Thoracic
Echocardiography (TTE) is considered an effective method to
determine ﬂuid responsiveness in mechanically ventilated patients
[11,12], however it has been proven to be inaccurate in spontaneous
ventilated critically ill patients [13], but there are little data in non-
critical patients [14]. IVC ultrasound study is based on measuringnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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imately 2 cm from the right atrium) through a subcostal view, and
on its diameter’s changes with breathing, both in spontaneously
breathing and in mechanical ventilated patients (Fig. 1).
Passive leg raising test (PLRT) has been shown to be a highly
accurate method in predicting ﬂuid responsiveness in spontane-
ously breathing critically ill patients [15]. The method is based on
the following assumption: active leg elevation, in addition to its
effect of venous pool shifting from the lower limbs to the chest,
exerts a simultaneous stimulation effect on the iliac-femoral peri-
arterial sympathetic system, causing an orthosympathetic reﬂex
which can increase cardiac output (Fig. 2). Alternatively, passive
lower limb test has the advantage of mobilizing lower limb venous
blood (estimated 300e500 ml) without activating the ortho-
sympathetic reﬂex. Thus, the test makes it possible to quantify the
clinical response after a bolus of ﬂuids [15].
We report our statistical analysis plan before performing the
outcomes assessment. We have conceived the ProCRHYSA trial
with the aim of determining whether these two non-invasive
methods are effective in guiding titrated ﬂuid repletion in non-
critical patients, both to decrease post-procedural signiﬁcant hy-
potension rate (primary end-point), and to avoid unnecessary ﬂuid
overload in patients undergoing spinal anaesthesia in elective
surgical procedures [16] and to compare the time needed to com-
plete the entire anaesthetic procedure (secondary end-point).2. Methods
2.1. Design of the study
This trial is conducted in our Anesthesiology Unit beginning on
May 2014; Ethical Committee approved the protocol (Comitato
Etico Cantonale Ref. N. CE2796) [16e18] and written informed
consent is obtained from all subjects during pre-operative anaes-
thesiologist visit.
Here we report our statistical analysis plan before the trial
conclusion. This is an unblinded, randomized, single-center, pro-
spective, three-arm, parallel-group trial of a cohort of consecutive
patients undergoing spinal anaesthesia for any elective surgical
procedure scheduled under spinal anesthesia. Patients are screened
for exclusion criteria. If one of these is met patients are excluded
from the study.
Inclusion criteria:Fig. 1. IVC ultrasound analysis (subcostal view).- adult patients
- elective intervention requiring spinal anaesthesia
- classiﬁed according to the American Society of Anesthesiology
risk (ASA) as level I, II or III.
Exclusion criteria:
- patients requiring invasive blood pressure monitoring (arterial/
pulmonary catheter, thermo-dilution catheter);
- pre-existing hypotension deﬁned as two measurements of sys-
tolic arterial pressure less than 80 mmHg and/or mean arterial
pressure less than 60 mmHg;
- patients unable to give informed consent due to language bar-
riers, mental retard or any reduction in own ability to under-
stand or give own informed consent;
- patients in whom it was not possible to perform spinal anaes-
thesia due to patient’s refusal or technical difﬁculties in
sampling;
- patients with International Normalized Ratio (INR) greater than
1.5 and/or aPTT in therapeutic range (more than 1.5e2 times the
patient’s normal values) and/or anti-factor-Xa activity in ther-
apeutic range;
- patients with thrombocytopenia less than 50 G/l;
- parturients and pregnant women;2.1.1. Randomization and allocation
Eligible patients are allocated 1:1:1 to one of the three treat-
ment groups by randomization blocks via an electronic software
[19]. An investigator not involved in the enrolment handles the
randomization-list, in order to guarantee allocation concealment;
doctors enrolling patients do not have access to it. Patients are
randomised using the method of minimisation incorporating a
random element; the minimisation factors are: age (cut off 65
years), ASA status (level III or level I/II intended as “not III”), any
assumption of anti-hypertensive therapy (intended as B-blockers or
ACE-inhibitors), any psychoactive therapy (SSRI, tricyclic antide-
pressant, MAO-inhibitors). Patients can only be included and
randomised by an authorised member of staff as detailed on the
delegation form.
Each participant is followed-up till the end of surgical operation;
participation in the study begins when patient enter the operating
block (time 0) and ends 30 min after spinal anaesthesia; different
study frames are classiﬁed as:
 Pre-anaesthetic phase: from time 0 to the execution of spinal
anaesthesia
 Anaesthetic phase: from the beginning to the end of the spinal
anaesthesia
 Post-anaesthetic phase: from the end of spinal anaesthesia to
30 min after the conclusion of the procedure.Fig. 2. Passive leg Raising Test.
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plications related to hypotension after spinal anaesthesia (cerebral
ischemia, neurological deﬁcit related to hypotension, chest pain,
myocardial ischemia/infarction, renal failure, cardiac arrest and all
clinical complication due to iatrogenic hypotension) are checked till
the end of the surgical procedure.
2.1.2. Safety
To reduce the risk of exposing patient to hypotension or to a
ﬂuid overload, we exclude patients with ASA score equal or greater
than IV. The use of both TTE than PLRT were assumed to be risk-
free. All serious adverse events and side effects are recorded in
the electronic case report form (eCRF) throughout the study
regardless of their relation to study participation. The principal
investigator submits a weekly report of all SAEs (expected and
unexpected) to the Ethics Committee; the study may be prema-
turely discontinued on the basis of eventual new safety concerns by
the research Ethics Committee or sponsor concerned.
2.1.3. Setting
All patients are scheduled for elective surgical procedures under
spinal anesthesia in the operating suits of Bellinzona Regional
Hospital, Bellinzona (Switzerland).
During the induction phase, patients are monitored with non-
invasive blood pressure, three-lead ECG, pulse-oxymetry. These
parameters are recorded in the data collecting sheet. Total amount
of ﬂuid is recorded before and after spinal anaesthesia. Spinal
anaesthesia technique is standardized for every patient: patients
are positioned in lateral decubitus, L3-L4 space is identiﬁed and
spinal anaesthesia administered via a 27G pencil point beveled
spinal needle (BBraun, Melsingen, Germany). A standard dose of
bupivacaine 0.5% 10 mg is slowly injected with needle oriented
cranially and no barbotage. After injection, patients are immedi-
ately positioned supine for 30 min before the beginning of surgery,
than NIBP is measured every minute and recorded in a data col-
lecting form. If the patient develops any sign or symptom of hy-
potension, he/she is treated according to standard internal protocol
with a crystalloids bolus and eventually with neosynephrine,
ephedrine or atropine according to the clinical setting. Total
quantity and type of amine used is also recorded.
2.1.4. Interventions
In the IVC ultrasound group, a TTE is performed before spinal
anaesthesia, with the aim of assessing patients’ volume status; in
particular, the exam is performed to assess size and collapse of the
IVC during breathing. According to a set of pre-established pa-
rameters [13], patients are deﬁned as ﬂuid-responsive or unre-
sponsive; we use the echocardiographic evaluation of IVC with M-
mode during spontaneous breathing, adopting a cut-off value of
collapsibility of 36% from baseline in order to deﬁne a patient as
ﬂuid-responsive [13]. If the patient is not responsive, investigators
proceed to spinal anaesthesia; otherwise they administer a crys-
talloid bolus (500 ml of NaCl 0.9% or Hartmann’s solution). Patients
are than re-assessed and they may receive further boluses until
reaching a non-responsive echocardiographic pattern. After spinal
anaesthesia, patients are immediately positioned supine for 30 min
before the beginning of surgery.
In the passive legs raising arm of the study (PLRT), a measure-
ment of etCO2 with patients in semi-recumbent position (45) was
performed [15]. Measurements were performed before and after
the test (after 60e90 s): an etCO2 increase of 5% from baseline is
interpreted as ﬂuid-responsive. If the patient is not responsive in-
vestigators proceed to spinal anaesthesia, otherwise they admin-
ister a ﬂuid bolus (500 ml of crystalloid) and reassess him/her, until
no response to ﬂuids is found. After spinal anaesthesia patients areimmediately positioned supine for 30 min before the beginning of
surgery.2.2. Data collection
All investigator ﬁll the CRF in during the anaesthetic procedure
reporting all demographic data (age, sex, weight and height), date
and hour of the procedure, all vitals parameters (NIBP, heart rate
and peripheral arterial saturation), some pre-procedural clinical
data (ASA score, anti-hypertensive therapy, procedure timing),
post-procedural clinical data (lowest NIBP value, heart rate and
oxygen saturation, eventual symptoms of hypotension), need for of
amines and total amount of ﬂuid administered (Table 1). These data
are subsequently collected in the electronic data base (EDC).
Data management procedures for the trial are developed and
overseen by the Ciesse-Sistemi; all data are registered in the EDC
system; this system is compliant to the Good Clinical Practice
standards. An eCRF using the EDC is programmed by Ciesse-Sistemi
in collaboration with the principal investigator and the statistician
and hosted on a dedicated secure server within the hospital. The
eCRF system has full audit trail, data discrepancy functionality,
database lock functionality and log reporting. The Ciesse-Sistemi
provides training, the essential documentation, and user support
to the study centres and remote monitoring; a detailed standard
operating procedure regulates data recording, online entry,
checking, central backup and storage. A regularly updated coding
manual is developed with regard to the study database. Each
investigator has a personal username and password for the eCRF.
Baseline data are collected and entered by researchers before
the randomisation; to each enrolled patient is assigned a unique
trial identiﬁcation number at the beginning of the assessment
process. This number is written on all clinical assessment forms,
datasheets and databases used to record participant data. The
datasheets are checked for completeness and accuracy at the end of
the entire procedure. A hard copy of a record sheet linking patient
identity, contact details and trial ID number for all participants is
stored in accordance to clinical trial GCP regulations.
Each investigator transcribes data into the eCRF; the Clinical
Trial Unit reviews the data and eventual inquiries are addressed to
the investigator concerned. At the end of the trial, the principal
investigator reviews all the data for each participant and provides
electronic sign-off to certify that all data are complete and correct,
in order to be approved to undergo statistical analysis.2.3. Objectives of study
Primary objective:
 To compare rates of arterial hypotension [16] after spinal
anaesthesia in patients undergoing inferior vena cava US guided
versus PLRT guided volemic optimization. Signiﬁcant hypoten-
sion is deﬁned, according to international guidelines, as a fall in
systolic arterial blood pressure of either more than 50 mmHg or
more than 25% from the baseline value, an absolute value of
systolic pressure less than 80 mmHg, an absolute value of mean
pressure of less than 60 mmHg, a reduction in mean arterial
pressure of more than 30% from the baseline value and/or
clinical signs/symptoms of inadequate perfusion [20].
Secondary objectives:
 To compare rates of arterial hypotension after spinal anaesthesia
in patients undergoing volemic optimization according to PLRT
with patients treated according to the current clinical standards.
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in patients undergoing volemic optimization according to vena
cava ultrasound with patients treated according to the current
clinical standards.
 To carry out subgroup analyses in order to determine the effects
of the vena cava ultrasound and PLRT methods on arterial hy-
potension after spinal anaesthesia according to: age, ASA score,
anti-hypertensive and anti-psychotic therapy.
 To assess an eventual difference between the three treatments
in the quantity of ﬂuids administered in the pre-anaesthetic
phase (from time 0 to spinal anaesthesia).
 To assess if there is a difference between the three treatments in
the total quantity and the quantity of vasoactive drugs required.
 To compare the time needed to complete the entire anaesthetic
procedure into the three groups.2.4. Ethical issues
The conduction of this study is in accordance with the recom-
mendations for physicians involved in research on human subjects
adopted by the 18th World Medical Assembly, Helsinki 1964 (and
later revisions). This protocol and related documents have been
approved by the National Research Ethics Service Committee Lon-
don - Dulwich. Local approval is required before recruitment. The
Study Coordination Centre requires a written copy of all the
documentation before starting to recruit participants into the
study. TTE and PLRT are non-invasive tests known risks. During the
pre-clinical assessment, investigators explain all study details [18].
When it is not possible to obtain consent for whatsoever reasons,
the patient cannot be involved.
2.5. Statistical analyses
2.5.1. Sample size calculation
From previous studies21 we estimate the incidence of arterial
hypotension after spinal anesthesia to be of about 50% in the
standard treatment group [22e28]. In order to have a signiﬁcant
difference between each treatment group, with a power of 80% and
a signiﬁcance level of 0.05 (two-tailed z test) we calculated a
numerosity of 170 patients per group (G-Power 3.1.5). Based on
patients routinely treated in last two previously year, we estimateTable 1
Summary of study assessment.
Summary of study assessment Baseline Pre-assessment Pre-anes
Registration/Demographics x
Informed consent x
Eligibility form x
Inclusion criteria x
Exclusion criteria x
Randomization x
Medical history x x
Concomitant medications x x
Systolic blood pressure x
Diastolic blood pressure x
Mean blood pressure x
Heart rate x
Peripheral saturation x
Type of ﬂuid administrated x
Quantity of ﬂuid administrated x
Time arrival-anesthesia x
Time anesthesia / post-anesthesia
Vasoactive drugs administered x
Withdrawl form x
SAE x
Adherence statusan accrual rate around 30e35 patients each month (low value 15
patients/month), with the necessity to enroll patient for 2 years.
The study ﬂow-chart is provided [21], including total patients
screened, number of patients who met inclusion and exclusion
criteria and number of patients who were included. To assess
randomization success, we tabulate the distribution of baseline
variables across the study’s sections, summarizing categorical var-
iables by frequencies and percentage and numerical variables
either by mean and standard deviations (±SDs), or by medians and
interquartile ranges (IQR).2.5.2. Adherence effects
For every patient, we check the adherence to the protocol during
the study; for each patient who didn’t completely meet the pro-
tocol, we wrote on the CRF the reasons. It could be linked to any
pre-anaesthetic ﬂuid administration different from crystalloid
infusion, administration of any sedation different than standard
therapy (Fentanyl more than 1 mg/Kg IV or Midazolam more than
0.05 mg/kg IV) both in quantity than in quality (Ketamine,
Morphine, etc …), post-anaesthetic position different than the su-
pine one or difference in spinal drug administration, both in
quantity (different than hyperbaric Bupivacaine 0.5% 10 mg) and in
quality (co-administration of any intra-thecal substance). We
assessed and report total adherence rate to our protocol in order to
analyse data on the intention-to-treat (ITT) and on the per-protocol
(PP) population. Primary analysis was carried out on the ITT pop-
ulation, which consisted of all patients enrolled in the study taken
in their randomized groups and irrespective of potential non-
adherence to the study protocol. Secondary analyses included
analysis on the PP population, which consisted of patients who
received ﬂuid replacement and all treatments as speciﬁed by the
protocol; our results of the analyses on the two populations were
compared. All hypothesis tests were two-sided and considered
signiﬁcant if p-value  0.05. Analyses were carried out with the
intention to treat if not otherwise speciﬁed.
Primary analysis:
 We tested the hypothesis of difference in the proportion of
arterial hypotension in subjects allocated to the TTE group and
in subjects of the standard treatment group, with the ITT. We
carried out a z-test for comparison of the two proportions. Thethesia Anesthesia Post-anesthesia End of trial Withdrawl
x
x x x
x x x
x x x
x x x
x x x
x x x
x x x
x x
x x x
x x x
x x x x
x x x x
x
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wasn’t accepted if the p-value was 0.05.
Secondary analyses:
 We tested the hypothesis of difference in the proportion of
arterial hypotension in subjects allocated to the PLRT group and
subjects of the standard treatment group, with the ITT analysis
and also on the per-protocol population. We carried out z-tests
for comparison of proportions.
 A z-test for comparison of two proportions was also applied to
test the hypothesis of difference in the proportion of arterial
hypotension in subjects allocated to the TTE group and subjects
of the standard treatment group, on the per-protocol population.
 We assessed the protective effect of the TTE and of the PLRT
methods compared to the standard method on the occurrence
of arterial hypotension by means of a univariable logistic
regression model. The outcome “arterial hypotension” was
binary coded (yes/no). We calculated crude odds ratio and their
relative 95% conﬁdence intervals (CI). A multivariable logistic
regression model was applied to account for potential con-
founders which consist of independent variables that were
deemed to be unbalanced after randomization process or that
are of clinical importance. This multivariable logistic regres-
sion model allowed calculating adjusted odds ratio with their
relative 95% CI.
 Explorative subgroup analyses was carried out to investigate the
effects of the TTE and the PLRT methods on arterial hypotension
after spinal anaesthesia according to different subgroups. The
subgroups of interest included the following variables: age (cut
off 65 years), ASA score (IeII vs III), assumption of B-blockers or
ACE-inhibitors (yes vs no), patient positioning after spinal
anaesthesia (supine vs lateral decubitus). We carried out
multivariable logistic regression models, to calculating the odds
ratio adjusted for the same baseline variables as previous
models, and their relative 95% CI.Fig. 3. ProCRHYSA tri We tested the hypothesis that there was a difference in the
quantity of ﬂuids (ml) administered to the subjects in each
groups in the pre-anaesthetic phase. We ﬁrst checked data
distribution; if this was shown to be normal we summarized the
total amount of ﬂuids by means and standard deviations (±SDs)
for each group; additionally, the comparison between the three
groups was carried out by one-way ANOVA (Analysis of vari-
ance) and post-doc tests. If data were not normally distributed
we summarized the amounts of ﬂuids by median and IQR car-
rying out the comparison by a Kruskal-Wallis test to assess, with
a non-parametric method, the null hypothesis of no difference
in the amount of ﬂuids between each groups. The null hypoth-
esis wasn’t be accepted if p-value was 0.05. If the distribution
of data allowed it, we applied multivariable linear regression
model to account for potential confounders which consisted of
independent variables that were deemed to be unbalanced after
randomization process or that were of clinical importance.
 We tested the hypothesis that there was a difference in the total
amount of ﬂuids (ml) and in the quantity of administered drugs
(mg) as well as in the time needed to complete the entire
anaesthetic procedure in the three groups the same way as for
the amount of ﬂuids in the pre-anaesthetic phase (see above).2.5.3. Missing data
Missing data due to incomplete CRF or withdrawal from the
study were left empty and were not be completed later. Subjects
were not be replaced.2.6. Figures and tables
Planned ﬁgures include:
 a standard CONSORT ﬂow diagram [29] illustrating patients’
ﬂow through the trial (Fig. 3);al ﬂow diagram.
S. Ceruti et al. / Contemporary Clinical Trials Communications 4 (2016) 39e4544 a graph showing the mean cumulative ﬂuids received in all
three groups;
 a graph showing hypotension rate in all groups and subgroups;
Planned tables include:
 baseline characteristics by treatment group;
 clinical management by treatment group;
 non-compliance with allocated treatment by all three treatment
groups;
 primary and secondary outcomes by treatment group;
 serious adverse events until the end of surgical operation;
 results of subgroups and secondary analyses;
3. Discussion
To the best of our knowledge this is the ﬁrst study to investigate
the potential role of non-invasive methods (like TTE and PLRT) to
accomplish a titrated and targeted volemic optimization before
spinal anesthesia in elective surgical patients in order to prevent
hypotension.
Post-spinal transient hypotensive episodes can be generallywell
tolerated by healthy patients, however they may lead to major
complications in patients with increased cardiovascular risk. In the
common clinical practice, it is usual to administer ﬂuids empiri-
cally. An empirical preventive ﬂuid repletion however can repre-
sent per se a risk in patients with impaired cardiac and renal
functions, since a volume overload in case of reduced ventricular
compliance, can cause pulmonary oedema or congestive heart
failure.
Since about ten years both non-invasive and invasive techniques
have been developed, with the speciﬁc purpose of optimizing ﬂuid
status on a more rational basis. This methods are based on the
correlation between the levels of mean arterial pressure (MAP),
systemic vascular resistance (SVR) and cardiac output (CO), ac-
cording to the equation: MAP ¼ CO * SVR. The latter explains why,
in case of vasodilation, unless CO is increased, a lowering of SVRwill
inevitably cause a decrease of MAP. Determinants of blood pressure
are: volemic status, vascular resistances (determined by the sym-
pathetic tone) and cardiac output. In case of spinal anaesthesia the
reduction in SVR causes relative hypovolemia. For this reason after
spinal anaesthesia is often necessary an optimization of patients’
volemic status through ﬂuids administration.
The use of different methods to assess ﬂuid responsiveness in
order to guide volume repletion avoiding blind ﬂuid challenges has
been extensively studied in critical care populations, however these
techniques have never been studied in non-critical patients. The
hypothesis that investigators want to test is that the use of TTE and
PLRT before spinal anaesthesia, compared to an empirical ﬂuid
administration can reduce the rate of systemic hypotension
through a titrated volemic repletion, avoiding both hypotension
and ﬂuid overload. The ﬁnal purpose is to administer spinal
anaesthesia in the safest possible way.
Trial status
The ProCRHYSA trial is still ongoing at the time of submission,
since patients recruitment has not been completed yet.
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